Management also pointed to a volatile macro environment, including trade tensions, geopolitical fragmentation, and slowing major economies. Avolio said global uncertainties affected production decisions and inventory replenishment and contributed to lower resin spreads versus 2024. In Brazil, she said domestic resin demand fell about 2% in 2025 after a 60% growth year in 2024, as downstream converters optimized inventories.In Brazil, utilization rates for petrochemical complexes were 4 percentage points low ...

Braskem (NYSE:BAK) Q4 2025 Earnings call March 27, 2026 10:00 AM ET Company Participants Felipe Montoro Jens - CFO and Investor Relations Officer Roberto Ramos - CEO Rosana Cristina Avolio - Director of Investor Relations, Strategic Planning, and Market Intelligence Operator Good morning, and thank you for waiting. Welcome to Braskem's video conference to discuss our results for Q4 2025 and the year 2025. Today, we have with us Mr. Roberto Ramos, CEO, Felipe Jens, CFO, and Rosana Avolio, Investor Relations, ...

Operator Good morning, and thank you for waiting. Welcome to Braskem's video conference to discuss our results for Q4 2025 and the year 2025. Today, we have with us Mr. Roberto Ramos, CEO, Felipe Montoro Jens, CFO, and Rosana Avolio, Investor Relations, Strategic Planning, and Market Intelligence Director. Please note that this event is being recorded. Company Participants Felipe Montoro Jens - CFO and Investor Relations Officer Roberto Ramos - CEO Rosana Cristina Avolio - Director of Investor Relations, St ...

Braskem (NYSE:BAK) Q4 2025 Earnings call March 27, 2026 10:00 AM ET Speaker1Good morning, and thank you for waiting. Welcome to Braskem's video conference to discuss our results for Q4 2025 and the year 2025. Today, we have with us Mr. Roberto Ramos, CEO, Felipe Montoro Jens, CFO, and Rosana Avolio, Investor Relations, Strategic Planning, and Market Intelligence Director. Please note that this event is being recorded. The presentation will be delivered in Portuguese with live translation and simultaneous in ...

DISCLAIMER REGARDING FORWARD-LOOKING STATEMENTS This presentation may contain forward-looking statements. These statements are not historical facts and are based on the Company's current vision and estimates of the Company's management regarding future economic and other circumstances, industry conditions, performance and financial results, including any potential or projected impact related to Alagoas and related legal proceedings on the Company's business, financial condition and operating results. The wo ...

Core Viewpoint - Brazil's anti-trust regulator CADE has approved IG4 Capital's acquisition of a controlling interest in Braskem from Novonor, marking a significant shift in ownership within the petrochemical sector [1][2]. Group 1: Acquisition Details - The deal is valued at approximately 20 billion reais, involving credit secured by Braskem shares held by major Brazilian banks [2]. - IG4 Capital will share control of Braskem with Petrobras, which is the second-largest shareholder, while Novonor will retain a minor 4% stake in the company [3]. - The acquisition will involve a debt-to-equity swap, allowing IG4 to gain control without a direct share purchase [3]. Group 2: Regulatory Approval Process - CADE's approval is set to become official unless an appeal is filed within 15 days by any third party or CADE's administrative tribunal [2]. - The ruling also permits the acquisition of Novonor-linked credit rights by Shine I FIDC, which is backed by Braskem shares and is part of Novonor's asset restructuring plan [4]. - CADE conducted a thorough review starting in February due to concerns about the implications of integrating an investment fund into Braskem's capital structure [5]. Group 3: Novonor's Financial Strategy - Novonor is undergoing judicial recovery and aims to divest most of its holdings in Braskem while keeping a small stake as part of its recovery strategy [6].

Core Thesis - Braskem S.A. is viewed as a distressed equity opportunity, trading significantly below its replacement cost, with potential for substantial upside if governance and cyclicality improve [1][4]. Company Overview - Braskem S.A. is a Brazilian petrochemical company with a market cap of $1.15 billion and an enterprise value of $8.15 billion, trading at $2.86 per ADR [1]. - The company operates four integrated complexes in Brazil, an ethane cracker in Mexico, five plants in the U.S., and two in Germany, with a replacement cost exceeding $20 billion [1]. Operational Strengths - The Brazilian operations benefit from a natural moat due to tariffs and freight costs that protect domestic pricing [2]. - The joint venture in Mexico, Braskem Idesa, has resolved feedstock supply issues and is now operating at full commercial capacity following the construction of an ethane import terminal [2]. Challenges and Resolutions - Historical challenges include the Alagoas salt mining disaster, which has been largely resolved, and governance issues stemming from the controlling shareholder Novonor's past troubles [2]. - A potential acquisition of Novonor's 38.3% stake by IG4 Capital could alleviate the distressed-seller overhang and align management incentives, although Petrobras' approval is still necessary [3]. Financial Performance - Recent earnings have been affected by cyclical headwinds, with Q3 2025 recurring EBITDA reported at R$818 million and a net loss of R$174 million [3]. - The balance sheet is positioned to provide runway until a sector recovery occurs [3]. Future Projections - Mid-cycle projections for 2027 suggest an enterprise value of R$16.8 billion, indicating a potential upside of 700–800% from the current market price [4]. - The company is seen as a rare distressed equity opportunity, trading well below replacement cost, with significant upside potential if governance and cyclicality normalize [4].

Core Viewpoint - The Australian IPO market is currently facing challenges, with a lack of new listings and a recent withdrawal of Barkly Rare Earths from its planned IPO, indicating a continued struggle for new company listings despite some optimism in the metals market [1][2][5]. Group 1: IPO Market Status - Unity Metals recently listed on the ASX, marking the first IPO of the calendar year 2026 [1]. - Barkly Rare Earths has postponed its listing from January 22 to an indefinite status, contributing to a bleak outlook for new IPOs [1][5]. - The easing of ASX IPO listing rules last year has not significantly improved the situation, as the market still resembles the IPO drought experienced in late CY23 [2][3]. Group 2: Upcoming Listings - Two upcoming IPOs are scheduled for February: Eastern Gas Corporation aiming to raise $5.5 million and Macallum New Energy targeting $9 million, both categorized as smaller listings [6]. - There is a notable absence of larger, high-profile companies looking to list, with Canva confirming it will not pursue an ASX IPO, leaving investors awaiting a significant listing [6]. Group 3: Market Sentiment - Despite the recent enthusiasm in metals prices, the overall sentiment in the IPO market remains cautious, with stockbrokers returning from holidays in anticipation of new listings [2][4]. - The current environment suggests that investors who favor IPOs may find limited opportunities in the near term [5].

Group 1 - Petrobras and IG4 plan to implement alternate control over Brazilian chemical producer Braskem [1] - This strategic move indicates a shift in ownership dynamics within the Brazilian chemical industry [1] - The collaboration aims to enhance operational efficiency and market positioning for Braskem [1] Group 2 - The involvement of Petrobras, a state-controlled oil giant, highlights the significance of energy companies in the chemical sector [1] - IG4's participation suggests a growing interest from private equity in the Brazilian chemical market [1] - This development may lead to increased investment and innovation within Braskem, impacting the broader chemical industry landscape in Brazil [1]

Core Viewpoint - Momentum investing focuses on "buying high and selling higher," contrasting with traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investing can be risky as stocks may lose momentum if future growth does not justify high valuations [1] - A safer approach is to invest in bargain stocks that exhibit recent price momentum, identified through the Zacks Momentum Style Score [2] Group 2: Braskem (BAK) Stock Analysis - Braskem (BAK) has shown a four-week price change of 1.4%, indicating growing investor interest [3] - Over the past 12 weeks, BAK's stock gained 18.6%, with a beta of 1.89, suggesting it moves significantly more than the market [4] - BAK has a Momentum Score of A, indicating a favorable time to invest [5] - The stock has a Zacks Rank 2 (Buy) due to upward revisions in earnings estimates, which attract more investors [6] - BAK is trading at a low Price-to-Sales ratio of 0.09, meaning investors pay only 9 cents for each dollar of sales, indicating a reasonable valuation [6] Group 3: Additional Investment Opportunities - Besides BAK, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, suggesting further investment opportunities [7] - Zacks offers over 45 Premium Screens tailored to different investing styles, aiding in stock selection [8]